Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
Johnson and Johnson
Express Scripts
QuintilesIMS
Teva
Baxter
Medtronic
US Department of Justice

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CLINDAMYCIN PHOSPHATE; TRETINOIN

« Back to Dashboard

Clinical Trials for Clindamycin Phosphate; Tretinoin

Trial ID Title Status Sponsor Phase Summary
NCT00823901 Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea Completed Medicis Pharmaceutical Corporation Phase 2/Phase 3 The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel are effective and safe in the treatment of papulopustular rosacea.
NCT00823901 Safety and Efficacy Study of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel to Treat Rosacea Completed Massachusetts General Hospital Phase 2/Phase 3 The purpose of this study is to determine whether Clindamycin Phosphate 1.2% And Tretinoin 0.025% Gel are effective and safe in the treatment of papulopustular rosacea.
NCT00838812 Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate Completed Igefarma Laboratorios S.A. Phase 3 The purpose of this study is to determine the safety and efficacy of association between tretinoin and clindamycin phosphate on the treatment of acne vulgaris mild and moderate.
NCT01047189 Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris Completed Medicis Pharmaceutical Corporation Phase 4 The purpose of this research study is to evaluate the effectiveness of two different types of topical acne medication. This study will help to determine if one combined medication results in better acne improvement than two separate medications for acne.
NCT01047189 Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris Completed Wake Forest University Health Sciences need to be deleted Phase 4 The purpose of this research study is to evaluate the effectiveness of two different types of topical acne medication. This study will help to determine if one combined medication results in better acne improvement than two separate medications for acne.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Clindamycin Phosphate; Tretinoin

Condition Name

Condition Name for Clindamycin Phosphate; Tretinoin
Intervention Trials
Acne Vulgaris 5
Acne 1
Rosacea 1
MILD TO SEVERE ACNE VULGARIS 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Clindamycin Phosphate; Tretinoin
Intervention Trials
Acne Vulgaris 6
Neoplasm Metastasis 1
Hyperpigmentation 1
Rosacea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Clindamycin Phosphate; Tretinoin

Trials by Country

Trials by Country for Clindamycin Phosphate; Tretinoin
Location Trials
United States 7
India 1
Brazil 1
China 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Clindamycin Phosphate; Tretinoin
Location Trials
New York 2
Pennsylvania 1
Maryland 1
North Carolina 1
Massachusetts 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Clindamycin Phosphate; Tretinoin

Clinical Trial Phase

Clinical Trial Phase for Clindamycin Phosphate; Tretinoin
Clinical Trial Phase Trials
Phase 4 4
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Clindamycin Phosphate; Tretinoin
Clinical Trial Phase Trials
Completed 5
Unknown status 3
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Clindamycin Phosphate; Tretinoin

Sponsor Name

Sponsor Name for Clindamycin Phosphate; Tretinoin
Sponsor Trials
Zeichner, Joshua, M.D. 2
Medicis Pharmaceutical Corporation 2
Callender Center for Clinical Research 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Clindamycin Phosphate; Tretinoin
Sponsor Trials
Other 7
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Medtronic
Express Scripts
Federal Trade Commission
QuintilesIMS
Queensland Health
Cantor Fitzgerald
UBS
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.